Evaluation of the NovaSure Endometrial Ablation Procedure in Women With Uterine Cavity Length Over 10 cm

Thiel, John; Briggs, Matthew S.; Pohlman, Scott; Rattray, Darrien

doi:10.1016/s1701-2163(15)30562-4

Cited by 8 publications

(7 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We report that for women with a uterine cavity length of greater than 6.5 cm (group B), the amenorrhea rate was reduced (55.6%), however this was still comparable with published amenorrhea rates in recent literature [9] (Table 4). In comparison to the relevant literature, one study evaluated the use of NEA in women with total uterine lengths > 10 cm and reported a 51.9% rate of amenorrhea, which is lower than in the present study [15]. The success rate in women with endometrial cavity length 4-6.5 cm, endometrial cavity length more than 6.5 cm and overall was 98.9%, 77.8% and 96.9% respectively.…”

Section: Discussioncontrasting

confidence: 68%

“…Two out of these three women were from the group B with a uterine cavity > 6.5 cm in length, although this group contained only 9 patients. Our study reported a lower rate of hysterectomy (1.1%) in women with a uterine cavity length between 4-6.5 cm compared to published literature (4.0-8.9%) [12,15], however there was a higher rate of hysterectomy when the uterine cavity length was > 6.5 cm (22.2%).…”

Section: The Success and Failure Rates Of Novasurecontrasting

confidence: 73%

“…Amenorrhea Women who needed hysterectomy Clark [12] 14/25 (56.0%) 1/25 (4.0%) Penninx [13] 35/75 (46.7%) 4/75 (5.3%) Bongers [14] 34/83 (41.0%) 4/83 (4.8%) Campbell [10] 217/368 (59.0%) 28/386 (7.6%) Thiel [15] 100/168 (59.5%) 15/168 (8.9%) Current study 84/97 (86.6%) 3/97 (3.1%)…”

Section: Authormentioning

confidence: 99%

See 2 more Smart Citations

Outcome of Novasure Endometrial Ablation in Women with Heavy Menstrual Bleeding with or without Dysmenorrhoea, Including Those with Uterine Cavity Length More Than 6.5 cm

Gad¹,

Rigby²,

Vemuri³

et al. 2017

Obstet Gynecol Cases Rev

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 68%

Section: The Success and Failure Rates Of Novasurecontrasting

confidence: 73%

See 1 more Smart Citation

Outcome of Novasure Endometrial Ablation in Women with Heavy Menstrual Bleeding with or without Dysmenorrhoea, Including Those with Uterine Cavity Length More Than 6.5 cm

Gad¹,

Rigby²,

Vemuri³

et al. 2017

Obstet Gynecol Cases Rev

View full text Add to dashboard Cite

“…In addition, the NovaSure ablation technique was evaluated by Thiel et al [12] in 87 women with uterine length > 10 cm compared to 101 women with uterine length ≤ 10 cm (101 women). The authors concluded that the NovaSure endometrial ablation was associated with successful outcomes in women with uterine length > 10 cm, without any serious procedure-related adverse events.…”

Section: Kalkat and Cartmillmentioning

confidence: 99%

Complete amenorrhea following NovaSure endometrial ablation for resistant menorrhagia: a case report

Abdelazim¹,

Abu-Faza²,

Farag³

2018

MIS

View full text Add to dashboard Cite

“…In addition, the NovaSure ablation technique was evaluated by Thiel et al, in 87 women with uterine length > 10 cm compared to 101 women with uterine length ≤ 10 cm (101 women). The authors concluded that the NovaSure endometrial ablation was associated with successful outcomes in women with uterine length > 10 cm, without any serious procedure-related adverse events [12].…”

Section: Discussionmentioning

confidence: 98%

Complete amenorrhea after treatment of resistant menorrhagia using NovaSure ablation

Abdelazim¹,

Abu-Faza²,

Svetlana³

et al. 2018

jogi

View full text Add to dashboard Cite

Introduction: Heavy menstrual bleeding (HMB) or menorrhagia is the most common form of dysfunctional uterine bleeding (DUB). In spite of medical treatment for DUB, many women will eventually require a hysterectomy, which is an invasive treatment option. NovaSure ablation offers a same-day non-invasive alternative to hysterectomy and hysteroscopic ablation. Case description: A 38-year-old woman presented with HMB in 2015. The attacks of HMB interrupted her lifestyle , and she refused to continue with medical treatment, which failed to resolve her symptoms. The patient was admitted to the hospital four times in 2015, due to anemia caused by the DUB. Medroxyprogesterone acetate and oral contraceptive pills failed to control the patient's bleeding episodes. Hysteroscopic examination of the uterine cavity showed a normal cavity, and the endometrial biopsy showed proliferative endometrium. She was counseled about NovaSure ablation as the last treatment option before hysterectomy. The NovaSure ablation procedure took 90 s, and the patient was discharged from the hospital 6 h after the procedure. At follow-up, the patient is completely amenorrheic, and she is satisfied with the NovaSure ablation results. Conclusions: This case report demonstrates that NovaSure endometrial ablation is a safe, effective, non-invasive alternative to hysteroscopic endometrial ablation for treatment of DUB.

show abstract

Evaluation of the NovaSure Endometrial Ablation Procedure in Women With Uterine Cavity Length Over 10 cm

Cited by 8 publications

References 13 publications

Outcome of Novasure Endometrial Ablation in Women with Heavy Menstrual Bleeding with or without Dysmenorrhoea, Including Those with Uterine Cavity Length More Than 6.5 cm

Outcome of Novasure Endometrial Ablation in Women with Heavy Menstrual Bleeding with or without Dysmenorrhoea, Including Those with Uterine Cavity Length More Than 6.5 cm

Complete amenorrhea following NovaSure endometrial ablation for resistant menorrhagia: a case report

Complete amenorrhea after treatment of resistant menorrhagia using NovaSure ablation

Contact Info

Product

Resources

About